Clinical Trial Update: Ivacaftor in French Patients With Cystic Fibrosis and a G551D Mutation

View source ↗

Summary

This clinical trial update reports the completion of a study evaluating Ivacaftor in French patients with cystic fibrosis carrying the G551D mutation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Ivacaftor (Kalydeco) (ivacaftor)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Cystic Fibrosis | Status: COMPLETED